Yanan Zhang develops microfluidic platforms for blood-based diagnostics and high-throughput analysis, and studies receptor signaling, neuroinflammation, and DNA damage responses in cancer and neurodegeneration—bridging assay development to translational biomarkers and therapy response assessment.